| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in IONS over the last quarter tilts toward selling: insiders offloaded a net 1,410 shares worth roughly $61K. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 242.8K | $9.95M | - | |
| Dir | 161.2K | $6.61M | - | |
| VP | 102.9K | $4.22M | - | |
| CFO | 82.7K | $3.39M | - | |
| VP | 77.1K | $3.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Joseph Baroldi65 | EVP, Chief Business Officer | Sale+OE10b5-1 | 15,000 | $68.01 | $1,020,210.00 | -32.0% | +15.7% | -36.3% | |
| Oct 2, 2025 | Eric Swayze67 | EVP Research | Sale+OE10b5-1 | 27,114 | $66.16 | $1,793,744.13 | -42.1% | +15.7% | -36.3% | |
| Oct 1, 2025 | Joseph H Wender57 | Director | Sell10b5-1 | 16,800 | $65.50 | $1,100,384.88 | -15.4% | +20.0% | -33.1% | |
| Sep 30, 2025 | Elizabeth L Hougen61 | EVP, Finance & CFO | Sale+OE10b5-1 | 49,800 | $65.26 | $3,249,733.86 | -31.1% | +22.3% | -31.7% | |
| Sep 30, 2025 | Richard S Geary66 | EVP, Chief Development Officer | Sale+OE10b5-1 | 57,900 | $65.24 | $3,777,668.13 | -42.1% | +22.3% | -31.7% | |
| Sep 30, 2025 | Patrick R. O'Neil63 | EVP CLO & General Counsel | Sale+OE10b5-1 | 25,300 | $64.62 | $1,634,921.48 | -30.7% | +22.3% | -31.7% | |
| Sep 12, 2025 | Patrick R. O'Neil63 | EVP CLO & General Counsel | Sale+OE10b5-1 | 1,700 | $64.58 | $109,787.19 | -2.9% | +25.3% | -14.2% | |
| Sep 9, 2025 | Patrick R. O'Neil63 | EVP CLO & General Counsel | Sale+OE10b5-1 | 21,000 | $64.56 | $1,355,661.30 | -26.9% | +26.6% | -13.0% | |
| Sep 9, 2025 | Joseph Baroldi65 | EVP, Chief Business Officer | Sale+OE10b5-1 | 11,950 | $62.16 | $742,838.29 | -27.2% | +26.6% | -13.0% | |
| Sep 5, 2025 | C Frank Bennett64 | EVP, Chief Scientific Officer | Sell10b5-1 | 6,000 | $59.60 | $357,580.80 | -6.8% | +33.6% | -5.1% |